0002012593 2025-01-01 2025-12-31 DEF 14A false 0002012593 RAPPORT THERAPEUTICS, INC. true true true <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><div style="font-style:italic;display:inline;">Policy Regarding Timing of Awards of Options and Other Option-Like Instruments </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee generally grants annual equity awards, including stock option grants to our named executive officers, in the first quarter of each fiscal year. In addition, new hires receive stock option grants at the time of their hiring. During 2025, our compensation committee did not take into account any material nonpublic information when determining the timing and terms of equity incentive awards, and we did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. During 2025, we did not grant stock options to our named executive officers during any period beginning four business days before and ending one business day after the filing or furnishing of a Form <div style="white-space:nowrap;display:inline;">10-Q,</div> <div style="white-space:nowrap;display:inline;">10-K</div> or <div style="white-space:nowrap;display:inline;">8-K</div> that discloses material nonpublic information. </div> false false false During 2025, we did not grant stock options to our named executive officers during any period beginning four business days before and ending one business day after the filing or furnishing of a Form <div style="white-space:nowrap;display:inline;">10-Q,</div> <div style="white-space:nowrap;display:inline;">10-K</div> or <div style="white-space:nowrap;display:inline;">8-K</div> that discloses material nonpublic information.